Topical Analgesics as Alternative First Line Agents
As the opioid crises continues to loom over the landscape of pain management, there is a growing interest among practitioners for alternative analgesia and delivery systems. As such, topical and transdermal therapeutic options are being utilized with greater frequency among pain practitioners. This presentation will address the advantages that topical analgesics have over systemically administered analgesics, including the ability to provide effective analgesia with reduced systemic drug levels, a factor particularly beneficial to the elderly. Also discussed will be how topical analgesics differ from transdermal delivery systems in that the latter's goal is to deliver systemic rather than local effects.
The educational design of this activity addresses the needs of physicians, physician assistances, nurse practitioners, nurses, pharmacists, psychologists, and social workers involved in the treatment of patients with pain.
- Identify anatomic targets for topical medications
- Evaluate active ingredients well suited for topical delivery
- Differentiate various formulations of topically applied medication
- Discuss the potential adverse reactions of various topical preparation
Jeff Gudin, MD
Attending Physician, Anesthesiology
University of Miami Miller School of Medicine
Statement of Need/Program Overview
As the opioid crisis continues to loom over the landscape of pain management, there is a growing interest among practitioners for alternative analgesia and delivery systems. As such, topical and transdermal therapeutic options are being utilized with greater frequency among pain practitioners. This presentation will address the advantages that topical analgesics have over systemically administered analgesics, including the ability to provide effective analgesia with reduced systemic drug levels, a factor particularly beneficial to the elderly. Also discussed will be how topical analgesics differ from transdermal delivery systems in that the latter's goal is to deliver systemic rather than local effects.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PAINWeek. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation
This educational activity for 0.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Global Education Group designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-23-054-H08-P)
This is a knowledge-based activity.
This activity was released on 5/10/2023 and is valid for one year. Requests for credit must be made no later than 5/10/2024.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions for Obtaining Credit
In order to receive credit, participants must attend the enduring activity in its entirety. Participants must also score at least a 70% on the post-test and submit it, along with the credit application and evaluation form, to the address/ fax number indicated. Statements of credit will be mailed within 4 to 6 weeks following the program.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
Reported Financial Relationship
Jeffrey Gudin, MD
Consulting Fee (e.g., Advisory Board):
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at PAINWeek have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PAINWeek do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
- 0.50 AANP
- 0.50 ACCME (All Other)
- 0.50 ACCME (MD/DO Only)
- 0.50 ACPE Pharmacy
- 0.50 ANCC
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)